Myf-6 Activators
The chemical class termed Myf-6 Activators comprises a diverse range of compounds that directly or indirectly enhance the functional activity of Myf-6, a critical protein in muscle development. AICAR, through AMPK activation, directly influences Myf-6 expression, promoting its role in muscle differentiation and growth. GW501516 activates PPARδ, directly impacting Myf-6 expression and promoting its functional activity in muscle differentiation and oxidative metabolism. BGP-15 indirectly influences Myf-6 by activating heat shock response pathways, leading to increased Myf-6 activity in processes related to muscle stress response and regeneration. YK-11, a selective androgen receptor modulator, directly impacts androgen receptors, enhancing Myf-6 expression in muscle cells.
A-769662, similar to AICAR, activates AMPK and positively influences Myf-6, particularly in processes related to muscle differentiation and energy metabolism. S107 modulates calcium signaling, indirectly enhancing Myf-6 expression and contributing to increased functional activity in muscle contraction and development. Bortezomib inhibits the proteasome, indirectly activating Myf-6 and promoting its role in muscle differentiation and maintenance. Dantrolene inhibits calcium release from the sarcoplasmic reticulum, enhancing Myf-6 expression in calcium-dependent signaling pathways involved in muscle contraction and development. Demethylzeylasteral inhibits the STAT3 pathway, leading to increased Myf-6 expression and enhancing its activity in muscle differentiation and regeneration. Enobosarm, a SARM, directly impacts androgen receptors, positively regulating Myf-6 and contributing to increased functional activity in muscle growth and differentiation. 4-aminopyridine enhances neuromuscular transmission, indirectly influencing Myf-6 through motor neuron activation and promoting increased Myf-6 expression in processes related to muscle contraction and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), a key player in Myf-6 regulation. Activation of AMPK by AICAR enhances Myf-6 expression by promoting its transcription. This direct activation influences Myf-6 in muscle cells, leading to increased functional activity in processes related to muscle differentiation and growth. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 activates PPARδ, which positively regulates Myf-6 expression. This direct activation of PPARδ by GW501516 influences Myf-6 in muscle cells, leading to increased functional activity in processes related to muscle differentiation and oxidative metabolism. | ||||||
BGP-15 | 66611-37-8 | sc-507452 | 10 mg | $375.00 | ||
BGP-15 activates heat shock response pathways, indirectly influencing Myf-6. Heat shock response is known to impact Myf-6 expression positively. The indirect activation by BGP-15 results in increased Myf-6 functional activity, particularly in cellular processes related to muscle stress response and regeneration. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 activates AMPK, similar to AICAR, directly influencing Myf-6 expression. The activation of AMPK by A-769662 enhances Myf-6 activity, particularly in cellular processes related to muscle differentiation and energy metabolism. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the proteasome, leading to the accumulation of factors that positively regulate Myf-6. The indirect activation of Myf-6 by Bortezomib, through proteasome inhibition, results in increased functional activity in processes related to muscle differentiation and maintenance. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene inhibits calcium release from the sarcoplasmic reticulum, impacting calcium-dependent signaling pathways involved in Myf-6 regulation. The modulation of calcium signaling by Dantrolene enhances Myf-6 expression, contributing to increased functional activity in processes related to muscle contraction and development. | ||||||
Ostarine | 841205-47-8 | sc-364559 sc-364559A sc-364559B | 5 mg 50 mg 1 kg | $275.00 $1580.00 $9364.00 | 1 | |
Enobosarm (Ostarine) acts as a SARM, directly impacting androgen receptors similar to YK-11. The activation of androgen receptors by Enobosarm enhances Myf-6 expression, contributing to increased functional activity in processes related to muscle growth and differentiation. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $38.00 $1155.00 $122.00 | 3 | |
4-aminopyridine enhances neuromuscular transmission, indirectly impacting Myf-6 through motor neuron activation. The modulation of neuromuscular transmission by 4-aminopyridine leads to increased Myf-6 expression, enhancing its functional activity in processes related to muscle contraction and development. | ||||||